Pediatric Hematology and Oncology

Papers
(The median citation count of Pediatric Hematology and Oncology is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Ruxolitinib for steroid-refractory graft versus host disease in pediatric HSCT: high response rate and manageable toxicity19
Gut microbial composition difference between pediatric ALL survivors and siblings18
COVID-19 outcomes in a large pediatric hematology-oncology center in Houston, Texas15
Primary prevention of stroke in children with sickle cell anemia in sub-Saharan Africa: rationale and design of phase III randomized clinical trial14
COVID19 in children with cancer in low- and middle-income countries: Experience from a cancer center in Chennai, India13
A phase I study of panobinostat in children with relapsed and refractory hematologic malignancies12
The effect of deferasirox on endocrine complications in children with thalassemia10
Electrostatic Complementarity of T-Cell Receptor-Alpha CDR3 Domains and Mutant Amino Acids Is Associated with Better Survival Rates for Sarcomas9
Disseminated intravascular coagulation in children with cancer: A systematic review9
Efficacy and safety of immunosuppressive therapy with or without eltrombopag in pediatric patients with acquired aplastic anemia: A Chinese retrospective study9
COVID-19 reinfection in two children with cancer9
Sociodemographic and clinical characteristics associated with vitamin D status in newly diagnosed pediatric cancer patients8
Azacitidine and prophylactic donor lymphocyte infusions after hematopoietic stem cell transplantation for pediatric high-risk acute myeloid leukemia8
Acute toxicity and outcome among pediatric allogeneic hematopoietic transplant patients conditioned with treosulfan-based regimens8
Distinctive phenotypes in two children with novel germline RUNX1 mutations - one with myeloid malignancy and increased fetal hemoglobin8
Challenges in the management of localized Ewing sarcoma in a developing country7
Outcomes of juvenile myelomonocytic leukemia patients after sequential therapy with cytarabine and 6-mercaptopurine7
Characteristics and prognosis of pediatric myeloid sarcoma in the cytogenetic context of t(8;21)7
Management and outcomes of pediatric septic thrombophlebitis: a case series7
Vascular endothelial growth factor response with propranolol therapy in patients with infantile hemangioma7
Imatinib-Induced Hypogammaglobulinemia in Children and Adolescents with Chronic Myeloid Leukemia7
Syrian and Turkish children with cancer: a comparison on survival and associated factors7
Assessing the Relationship between PTSS in Childhood Cancer Survivors and Their Caregivers and Their Quality of Life7
Efficacy and safety of eltrombopag in the first-line therapy of severe aplastic anemia in children6
Intravenous anakinra for tisagenlecleucel-related toxicities in children and young adults6
Caring for Children with Cancer in Africa during the COVID-19 Crisis: Implications and Opportunities6
Use of Tissue Plasminogen Activator as a Surrogate Measure for Central Venous Catheter Dysfunction and Survival Outcome in Children with Cancer: A Population-Based Retrospective Cohort Study6
The effect of cardiorespiratory fitness and physical activity levels on cognitive functions in survivors of childhood acute lymphoblastic leukemia6
The efficacy and safety of a homoharringtonine-based protocol for children with acute myeloid leukemia: A retrospective study in China6
Clinical variability in multifocal lymphangioendotheliomatosis with thrombocytopenia: a review of the literature6
Continuous deep sedation at the end of life in children with cancer: experience at a single center in Japan6
Traumatic lumbar punctures in diagnostic and intrathecal treatment punctures of pediatric hemato-oncology patients6
High grade gliomas in young children: The South Thames Neuro-Oncology unit experience and recent advances in molecular biology and targeted therapies6
Sorafenib in pediatric hepatocellular carcinoma from a clinician perspective6
Association of body mass index with toxicity and survival in pediatric patients treated with cisplatin-containing regimens6
Initial in vivo testing of TPO-receptor agonist eltrombopag in osteosarcoma patient-derived xenograft models by the pediatric preclinical testing consortium6
Prevention and control strategies in the diagnosis and treatment of solid tumors in children during the COVID-19 pandemic5
Outcomes of pediatric mixed phenotype acute leukemia treated with lymphoid directed therapy: Analysis of an institutional series from India5
When to suspect GATA2 deficiency in pediatric patients: from complete blood count to diagnosis5
Application of the Scale for the Assessment and Rating of Ataxia (SARA) in pediatric oncology patients: A multicenter study5
Arsenic trioxide in pediatric cancer – a case series and review of literature5
Characteristics of parental decision-making for children with advanced cancer who are offered enrollment in early-phase clinical trials: A systematic review5
Rituximab is highly effective in children and adolescents with Burkitt lymphoma in Risk Groups R2 to R45
Survival in patients with high-risk neuroblastoma treated without autologous stem cell transplant or dinutuximab beta5
Weight status and health behaviors of adolescents and young adults with sickle cell disease: The emerging risk for obesity4
Efficacy and safety of vemurafenib in Langerhans cell histiocytosis (LCH): A systematic review and meta-analysis4
ABCC4, ITPA, NUDT15, TPMT and their interaction as genetic predictors of 6-mercaptopurine intolerance in chinese patients with acute lymphoblastic leukemia4
Glucocorticoid resistance induced by ANXA5 overexpression in B-cell acute lymphoblastic leukemia4
Heterozygous CTLA4 splice site mutation c.458-1G > C presenting with immunodeficiency and variable degree of immune dysregulation in three generation kindred of Caribbean descent4
The announcement of treatment resistance from the pediatric oncologist’s point of view: a qualitative study4
Ultrasound in Hepatic Veno-occlusive Disease (HVOD) after Pediatric Hematopoietic Stem Cell Transplantation (HSCT): Comparison of Diagnostic Criteria Including the Pediatric Criteria of European Socie4
Spina bifida and pediatric cancers4
Immune thrombocytopenia following multisystem inflammatory syndrome in children (MIS-C) – a case series4
Outcome and prognostic factors in childhood B non-Hodgkin lymphoma from India: Report by the Indian Pediatric Oncology Group (InPOG-NHL-16-01 study)4
Lipid Apheresis to Manage Severe Hypertriglyceridemia during Induction Therapy in a Child with Acute Lymphoblastic Leukemia4
Secondary hemophagocytic lymphohystiocytosis in a Rubinstein Taybi syndrome patient4
Clinical characteristics and successful treatment outcomes of children and adolescents with Kaposi sarcoma in Southwestern Tanzania4
Combination therapy with sorafenib and celecoxib for pediatric patients with desmoid tumor4
Impact of the COVID-19 pandemic on health-related quality of life and anxiety in pediatric hematology/oncology patients4
The effects of NUDT15 and TPMT variants on mercaptopurine treatment in Vietnamese pediatric acute lymphoblastic leukemia patients4
Treatment of infantile fibrosarcoma associated to an abdominal aortic aneurysm with larotrectinib: a case report4
Resilience in adolescents with thalassemia4
Primary gastric lymphoma: A report of 16 pediatric cases treated at a single institute and review of the literature4
Post-transplant CD34+ selected stem cell boost as an intervention for declining mixed chimerism following reduced intensity conditioning allogeneic stem cell transplant in children and young adults wi3
Nutritional status as a predictor of adverse events and survival in pediatric autologous stem cell transplant3
Clinical Characteristics and Outcomes of 101 Children with Hemophagocytic Lymphohistiocytosis: A Four-Year Single-Center Experience from Egypt3
Current status of African pediatric oncology education efforts aligned with the Global Initiative for Childhood Cancer3
TPMT polymorphisms and minimal residual disease after 6-mercaptopurine post-remission consolidation therapy of childhood acute lymphoblastic leukaemia3
Predictors of severe adverse outcomes in febrile neutropenia of pediatric oncology patients at a single institute in Thailand3
Late effects care for childhood brain Tumor Survivors: A Quality-Improvement Initiative3
Accuracy of online medical information: the case of social media in sickle cell disease3
Gross motor disorders in pediatric patients with acute lymphoblastic leukemia and survivors: A systematic review3
Familial hemophagocytic lymphohistiocytosis induced by SARS-CoV-23
Retrospective analysis of predisposing factors for difficult lumbar punctures requiring image guidance in pediatric oncology patients3
Clinical value of RAG1 expression and IKZF1 deletions in Philadelphia negative pediatric B cell precursor acute lymphoblastic leukemia3
Fertility preservation education for pediatric hematology-oncology fellows, faculty and advanced practice providers: a pilot study3
Prevalence and Risk Factors for Pulmonary Embolism in Pediatric Sickle Cell Disease: A National Administrative Database Study3
Low expression of CTBP2 and CASP8AP2 predicts risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a retrospective cohort study3
Usefulness of functional splicing analysis to confirm precise disease pathogenesis in Diamond-Blackfan anemia caused by intronic variants in RPS193
Impact of minimal residual disease on relapse in childhood acute lymphoblastic leukemia: Lessons learnt from a tertiary cancer center in India3
Retrospective single-center experience with OEPA/COPDAC and PET-CT based strategy for pediatric Hodgkin lymphoma in a LMIC setting3
Hereditary red blood cell membrane defects. Detection of PIEZO1 mutations associated with SPTA1 mutations. An unusual clinical case of hereditary xerocytosis3
Heart rate response and chronotropic incompetence during cardiopulmonary exercise testing in childhood acute lymphoblastic leukemia survivors3
IL-10 and TNFα are associated with decreased survival in low-risk pediatric acute myeloid leukemia; a children’s oncology group report3
Analysis of survival rates and prognosis of hepatoblastoma in children: a retrospective study from a single center in China3
Complete and durable response to immune checkpoint inhibitor in a patient with refractory and metastatic hepatoblastoma3
Seasonal variation of respiratory viral infections: a comparative study between children with cancer undergoing chemotherapy and children without cancer3
Early mortality continues to be a barrier to excellent survival in childhood acute promyelocytic leukemia: a retrospective study of 62 patients spanning 17 years3
A brief review of the current knowledge on environmental toxicants and risk of pediatric cancers3
Safety and efficacy of deferasirox in patients with transfusion-dependent thalassemia: A 4-year single-center experience3
Breakthrough bleeding episodes in pediatric severe hemophilia a patients with and without inhibitors receiving emicizumab prophylaxis: a single-center retrospective review3
High dose methotrexate containing regimen in pediatric non-metastatic extremity osteosarcoma patients: experience from a tertiary cancer center in India2
Gut microbes in pediatric ALL survivorship2
Clinical profile, outcome and challenges in the management of pediatric Burkitt lymphoma: a single center experience2
Combined immunodeficiency with marginal zone lymphoma due to a novel homozygous mutation inIL-21Rgene and successful treatment with hematopoietic stem cell transplantation2
Two patients of trisomy 21 with transient abnormal myelopoiesis with hypereosinophilia without blasts in peripheral blood smears2
Retrospective analysis of high-dose chemotherapy followed by autologous stem cell transplantation for high-risk pediatric osteosarcoma2
Using surveillance to determine the number of individuals with sickle cell disease in California and Georgia, 2005–20162
Hemophagocytic lymphohistiocytosis associated with parvovirus B19-induced aplastic crisis in a hereditary spherocytosis patient: A case report and literature review2
The time to diagnosis and survival in children with solid tumors and lymphoma: results from a single center in Turkey2
Delayed diagnosis of Griscelli syndrome type 2 with compound heterozygote RAB27A variants presenting with pulmonary failure2
Effective hemostasis in children with Von Willebrand factor defects undergoing adenotonsillar procedures2
Clinical characteristics and outcomes of combined thrombolysis and anticoagulation for pediatric and young adult lower extremity and inferior vena cava thrombosis2
Study of the diagnostic criteria for hemophagocytic lymphohistiocytosis in neonatal and pediatric patients with severe sepsis or septic shock2
Complicated bleeding challenge and intraoperative safety strategies in a case of hemophilia a with rhabdomyosarcoma2
Outcome and complications of pediatric acute promyelocytic leukemia in Bangladesh2
Vincristine-induced neurotoxicity in pediatric patients with rhabdomyosarcoma: A retrospective analysis of clinical features and outcome2
Prevalence of the BRAF V600E mutation in Greek adults with Langerhans cell histiocytosis2
Superficial CD34-Positive Fibroblastic Tumor on the Chest Wall of an 8-Year-Old Girl: A Case Report and Literature Review2
Molecular genetic testing enabled the diagnosis of otherwise undiagnosable cases of pyruvate kinase deficiency2
Transient abnormal myelopoiesis in Down syndrome: Experience of long term follow up from a single tertiary center in Thailand2
Novel Strategy Involving High-Dose Chemotherapy with Stem Cell Rescue Followed by Intrathecal Topotecan Maintenance Therapy without Whole-Brain Irradiation for Atypical Teratoid/Rhabdoid Tumors2
MicroRNA-199a deficiency relates to higher bone marrow blasts, poor risk stratification and worse prognostication in pediatric acute myeloid leukemia patients2
Global caregiver concerns of SARS-CoV-2 vaccination in children with cancer: a cross-sectional mixed-methods study2
Assessment of cystatin C in pediatric sickle cell disease and β-thalassemia as a marker of subclinical cardiovascular dysfunction: a case-control study2
Association between in-line filtration and Type I hypersensitivity reactions in pediatric oncology patients receiving intravenous etoposide2
Clinical Profile and Outcomes of Primary Immunodeficiency and Malignancy in Childhood at a Tertiary Oncology Center in Developing Country2
Microsatellite instability-high is rare events in refractory pediatric solid tumors2
Intracerebral hemorrhage as a rare complication of imatinib in a Philadelphia chromosome positive acute lymphoblastic leukemia pediatric patient2
PASTEC - a prospective, single-center, randomized, cross-over trial of pure physical versus physical plus attentional training in children with cancer2
Prognostic significance of survivin expression in pediatric ewing sarcoma2
Association between Consumption of Cow’s Milk and Iron Deficiency Anemia in Children: Are There Roles for Hepcidin-25/Ferroportin? A Case-Control Study2
Delayed therapy initiation for a case with congenital leukemia with transient spontaneous regression2
Early Decline of Neuron-Specific Enolase during Neuroblastoma Chemotherapy is a Predictive Factor of Clinical Outcome2
Outcomes of blinatumomab based therapy in children with relapsed, persistent, or refractory acute lymphoblastic leukemia: a multicenter study focusing on predictors of response and post-treatment immu2
Egyptian experience in Langerhans cells histiocytosis: frequent multisystem affection and reactivation rates2
Clinical practice guidelines on management of infantile hemangioma: a systematic quality appraisal using the AGREE II instrument2
Nodular lymphocyte predominant Hodgkin lymphoma: Experience of Polish Pediatric Leukemia/Lymphoma Study Group2
Bilateral adrenal primary tumor in Stage 4S neuroblastoma: The Italian experience and review of the literature1
Epigenetic age acceleration among survivors of pediatric medulloblastoma and primitive neuroectodermal tumor1
IDH1 mutated acute myeloid leukemia in a child with metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria1
Managing pediatric chronic myeloid leukemia in Africa: the Botswana experience with two cases1
Comparison of outcomes of children with acute lymphoblastic leukemia treated with BMF protocol across 2 decades1
Impact of socio-behavioral measures implemented during the SARS-CoV-2 pandemic on the outcomes of febrile neutropenia episodes in pediatric cancer patients: a single center quasi-experimental pre-post1
Changes in anthropometrical status and body composition in children with cancer during initial chemotherapy1
Gonadal health in recipients of nonmyeloablative hematopoietic stem cell transplantation in children and adolescents with sickle cell disease1
German physicians’ perceptions and views on complementary medicine in pediatric oncology: a qualitative study1
Clinical profile and outcome of children with anaplastic large cell lymphoma treated with short-course chemotherapy – ten years experience from a tertiary care center in a LMIC1
Acute myeloid leukemia in a child with familial platelet disorder and a cryptic runx1 intragenic deletion1
Expression of YY1 in pro-B and T phenotypes correlation with poor survival in pediatric acute lymphoblastic leukemia1
Allogeneic hematopoietic stem cell transplantation in an adolescent with Prader-Willi syndrome – unique considerations1
The clinicopathological profile and value of multidisciplinary management of pediatric brain tumors in a low-income setting1
Acute liver failure in a four-year old girl during maintenance therapy of acute lymphoblastic leukemia1
Low EVI1 expression at diagnosis predicted poor outcomes in pediatric Ph-negative B cell precursor acute lymphoblastic leukemia patients1
Hypothyroidism in children with Hb E/β-thalassemia compared between those who received regular transfusion and those who underwent hematopoietic stem cell transplantation1
Multicenter real-world experience of the clinical efficacy and tolerance of pazopanib in high-risk pediatric solid tumors (PazoPed)1
Introducing isotonic fluids into pediatric oncology1
How to recognize inborn errors of immunity in a child presenting with a malignancy: guidelines for the pediatric hemato-oncologist1
The efficacy and safety of midazolam with fentanyl versus midazolam with ketamine for bedside invasive procedural sedation in pediatric oncology patients: A randomized, double-blinded, crossover trial1
Abdominal lymphadenopathy in children with Gaucher disease: Relation to disease severity and glucosylsphingosine1
Chemotherapy supply chain management, safe-handling and disposal in Ethiopia: the case of Tikur Anbessa specialized hospital1
Treosulfan-based conditioning in HSCT patients1
Epstein-Barr virus-associated lymphoproliferative disorder in a young child treated for Wilms tumor1
Very late recurrence of B-cell acute lymphoblastic leukemia masquerading as a pituitary tumor1
Assessment of depression in children and adolescents with sickle cell anemia in a low-resource setting: a comparative study1
Estimation of iron overload with T2*MRI in children treated for hematological malignancies1
KMT2A-rearranged diffuse large B-cell lymphoma in a child: a case report and molecular characterization1
Outcomes of a preoperative risk-based transfusion assignment protocol in sickle cell disease patients: a single-center retrospective study from Saudi Arabia1
Chlorhexidine gluconate (CHG) foam improves adherence, satisfaction, and maintains central line associated infection rates compared to CHG wipes in pediatric hematology-oncology and bone marrow transp1
The predictive utility of cytokines, procalcitonin and C-reactive protein among febrile pediatric hematology and oncology patients with severe sepsis or septic shock1
A chronic eyelid lesion in a child: multi-disciplinary approach to diagnosis, treatment and management of a highly atypical histiocytic lesion1
Hemolymphangioma invasion of R scapula and mediastinum: a rare case report1
Therapeutic drug monitoring of intravenous busulfan in Thai children undergoing hematopoietic stem cell transplantation: A pilot study1
Timely diagnostics and safe procedures in children with anterior mediastinal masses (AMMs): a qualitative review of the AMM protocol at BC Children’s Hospital in Vancouver BC1
Methotrexate concentrations and associated variability factors in high dose therapy of children with acute lymphoblastic leukemia and non-Hodgkin lymphoma1
Para-neoplastic optic neuritis presenting in a child with fusion positive localised para-testicular alveolar rhabdomyosarcoma1
Clinical review of COVID-19 in children and adolescents with cancer: Experience from a tertiary care center in East India1
Physician risk perceptions and surveillance practices for tyrosine kinase inhibitor long-term effects in pediatric CML1
A novel homozygous disruptive PRF1 variant (K285Sfs*4) causes very early-onset of familial hemophagocytic lymphohystiocytosis type 21
The pre-surgical factors that determine the decision to proceed to resection in children diagnosed with high-risk neuroblastoma in a resource limited setting1
Health-related quality of life among Malaysian pediatric survivors of central nervous system tumor1
SACCSG HL-2018. Barriers and enablers of a harmonized treatment protocol for childhood and adolescent Hodgkin lymphoma in South Africa1
MiR-143-3p Inhibits Cell Proliferation in Pedatric Acute Myeloid Leukemia via Inhibition of KAT6A1
Near-Haploid B-Cell Acute Lymphoblastic Leukemia in a Patient with Rubinstein-Taybi Syndrome1
Guillain-Barré syndrome after bortezomib therapy in a child with relapsed acute lymphoblastic leukemia1
How do you tell parents whose child has cancer that the treatment has failed: A qualitative study on pediatric oncologists’ practices1
Intrauterine Growth Retardation is a Risk Factor for Anthracycline Toxicity1
Sustained molecular response following a failed attempt of tyrosine kinase inhibitor discontinuation & the effects on growth in a child with chronic myeloid leukemia: not always a short story1
Delayed Granulocyte Colony-Stimulating Factor (G-CSF) Administration after Chemotherapy Reduces Total G-CSF Doses without Affecting Neutrophil Recovery in a Randomized Clinical Study in Children with 1
Evaluating the baseline survival outcomes of the “six Global Initiative for Childhood Cancer index cancers” in Africa1
The expression of PHOX2B in bone marrow and peripheral blood predicts adverse clinical outcome in non-high-risk neuroblastoma1
A single assessment of methotrexate levels at 42 hours permits safe administration and early discharge in children with lymphoblastic lymphoma and leukemia receiving high-dose methotrexate1
Impact of restrictive measures due to the Covid-19 pandemic on the incidence of immune thrombocytopenia in children: an Italian single center experience1
Toward 2030: SIOP Africa adopts the Global Initiative for Childhood Cancer1
The role of pain rehabilitation in an adolescent sickle cell disease population: a case series1
Thalassemia patients in transfussion dependent period and after hematopoietic stem cell transplantation: how are the psychiatric status and life quality of these patients?1
Fecal microbiota of adolescent and young adult cancer survivors and metabolic syndrome: an exploratory study1
Non-inferiority of fragmented care for high-risk pediatric neuroblastoma patients: a single institution analysis1
Dual enzyme therapy improves adherence to chemotherapy in a patient with gaucher disease and Ewing sarcoma1
Barriers to Accessing Fertility Preservation in Adolescents with Hodgkin Lymphoma in India1
The combination of clofarabine, etoposide, and cyclophosphamide shows limited efficacy as a bridge to transplant for children with refractory acute leukemia: results of a monitored prospective study1
Clinical outcomes and prognostic factors in children with B-cell lymphoblastic lymphoma (LBL) treated according to on modified BFM-90 protocol: Experience from a Tertiary cancer care center in India1
Rhabdomyosarcoma as the first presentation in Neurofibromatosis Type 1: case series and review of the literature1
Tyrosine kinase inhibitor treatment and long-term follow-up for metastatic malignant struma ovarii1
Intra-arterial chemotherapy for rhabdomyosarcoma1
Histiocytic sarcoma arising in a child affected by Burkitt lymphoma, with t(8;14)(q24;q32) positivity in both tumors1
Palifermin as primary mucositis prophylaxis in patients with B-cell Non-Hodgkin lymphoma: a case series1
Brachial plexus chloroma as a presenting feature of relapse in a child with KMT2A-rearranged acute lymphoblastic leukemia, a case report1
Pulmonary nodular lymphoid hyperplasia in pediatric patients with Hodgkin lymphoma1
The global challenge of treating disseminated LCH1
Fluoxetine-Induced Acquired Platelet Aggregation Defect: a Rare Cause of Oral Bleeding1
Osteosarcoma emboli presenting as chronic thromboembolic pulmonary hypertension in a child1
GATA2-related myeloid neoplasms in pediatrics: where do we stand?1
0.047078847885132